These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 4666634

  • 1. [Study of dopamine and noradrenaline in the brains of three patients with Parkinson's disease who died in the course of treatment with L-dopa].
    Buscaino GA, Sori A, Campanella G.
    Rev Neurol (Paris); 1972 Aug; 127(2):301-2. PubMed ID: 4666634
    [No Abstract] [Full Text] [Related]

  • 2. Dopaminergic nervous transmission in Parkinson's disease.
    Rinne UK, Sonninen V, Riekkinen P, Laaksonen H.
    Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255
    [No Abstract] [Full Text] [Related]

  • 3. Cerebral catecholamine concentration after L-dopa therapy in Parkinson's disease.
    Greer M, Anton AH.
    Trans Am Neurol Assoc; 1970 Jun; 95():247-8. PubMed ID: 4328099
    [No Abstract] [Full Text] [Related]

  • 4. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W.
    Wien Klin Wochenschr; 1971 Apr 02; 83(13):221-7. PubMed ID: 4254333
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Brain dopamine and noradrenaline in 3 Parkinsonians deceased during L-dopa treatment.
    Buscaino GA, Jori A, Campanella G.
    Acta Neurol (Napoli); 1972 Apr 02; 27(6):537-44. PubMed ID: 4651485
    [No Abstract] [Full Text] [Related]

  • 7. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A, Bartholini G, Gey KF, Jenni A.
    Schweiz Med Wochenschr; 1970 May 09; 100(19):797-804. PubMed ID: 4924275
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease.
    Mars H.
    Trans Am Neurol Assoc; 1973 May 09; 98():241-5. PubMed ID: 4784941
    [No Abstract] [Full Text] [Related]

  • 10. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M.
    Psychiatr Neurol Neurochir; 1971 May 09; 74(4):331-3. PubMed ID: 5146239
    [No Abstract] [Full Text] [Related]

  • 11. [The therapeutic use of L-DOPA in Parkinson's disease. Biochemical, pharmacological and clinical considerations].
    Morselli PL, Rizzo M, Tognoni G.
    Recenti Prog Med; 1970 Feb 09; 48(2):97-124. PubMed ID: 5467589
    [No Abstract] [Full Text] [Related]

  • 12. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R.
    Med Klin; 1969 Aug 15; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract] [Full Text] [Related]

  • 13. Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease.
    Streifler M, Vardi Y, Kesten M, Oberman Z, Herzberg M.
    Isr J Med Sci; 1972 May 15; 81(5):597-601. PubMed ID: 5042950
    [No Abstract] [Full Text] [Related]

  • 14. The probenecid test in Parkinson's disease.
    Lakke JP, Korf J, Hoorntje S, Schut T, van Praag HM.
    Psychiatr Neurol Neurochir; 1973 May 15; 76(2):139-46. PubMed ID: 4700931
    [No Abstract] [Full Text] [Related]

  • 15. L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions.
    Davidson L, Lloyd K, Dankova J, Hornykiewicz O.
    Experientia; 1971 Sep 15; 27(9):1048-9. PubMed ID: 5116129
    [No Abstract] [Full Text] [Related]

  • 16. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J, Schmidt WJ.
    Behav Brain Res; 2004 May 05; 151(1-2):191-9. PubMed ID: 15084435
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Study of 3-4-dihydroxyphenylacetic acid, a dopamine catabolite, in patients with Parkinson's disease before treatment with L-dopa].
    Samson M, Bohuon C, Augustin P, Comoy E, Pouliquen A.
    Rev Neurol (Paris); 1972 Aug 05; 127(2):315-7. PubMed ID: 4666641
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.